Editor's Comments

by Admin 1. April 2008 14:08

     

 

 

 

Let’s get it on

Spring is here. The temperature is rising, the trees are growing new leaves, and the minds of healthcare sales and marketing professionals turn with new vigour to their two main preoccupations: love and money. In a spirit of bioscientific awareness and bold innovation, we have given some thought to the commercial application of the romantic urge: the theme of this issue of On Target is people getting together and forming new relationships.

Our lead article, ‘Devices and drugs: a modern marriage’, looks at how drug delivery devices offer a clinical and business model that unites the interests of medtech and pharma companies.

Martin Goldman considers the fertile but potentially dangerous liaisons between the two industries – from the doomed romance of Exubera to the long-running public affair of the drug-coated stent. He concludes that while both legal and medical advice are necessary for the nervous young medtech company, the call of true love may last beyond the initial joys of market penetration.

The next article, ‘All together now’, looks at how the Government’s plan to unite a broad range of primary and secondary healthcare services in ‘polyclinics’ will mean significant new opportunities for the medtech industry to meet customers and build relationships. Tony Davis goes on to discuss the framework the polyclinics will offer for the adoption of ehealth – an even better use for new technology than sending flirtatious text messages and e-mails.

In an exclusive On Target interview, Sir Michael Rawlins, the Chairman of NICE, discusses what the Institute is doing to support innovative health technologies. His message is clear: “We want new forms of medical technology that will improve the health of patients at a price the NHS can afford.” Among the issues he highlights are the meaning of innovation, the value of new data handling technology, the importance of preventative healthcare and the need for better ways to treat long-term conditions. All key issues for medtech companies keen to get close to the NHS.

In ‘Are we there yet?’ Chris Cummings offers a guide to account management in healthcare sales. Like dating, account management is all about communicating well, establishing a relationship of trust and giving as much as you get. He lists one of the “deadly sins” of poor account managers as “Failing to find out what customers truly want.” At least in the world of healthcare sales, you have clearly identifiable means of finding that out.

In keeping with this issue’s theme, our coverage of news and events in the UK healthcare sector highlights the emergence of new talent, the building of new relationships and the value of new devices. As the late Frankie Howard might have said, they’re all at it. So whether your style is the quick sale or the long-term contract, now’s the time to be looking for that special someone – the customer!

Chris Ross
Editor

 

 

 

In the seventh of our series on healthcare industry professionals, Duncan Mills, Sales Manager for Telehealth Solutions Ltd, talks to On Target about his working life.

What is the chief product line that you sell? Who are your customers?

We have two main products: the Surgery Pod and the Home Pod. The Surgery Pod goes into a GP surgery or other health area (such as a pharmacy). It enables patients to carry out basic health checks for themselves: blood pressure, weight, alcohol consumption, personal anxiety questionnaires – all the common questions that doctors and nurses usually have to go through when seeing a patient. It can be kept in a separate room or in the reception area. The Surgery Pod is purchased mostly by GP surgeries, although we’re also gaining increased traction with the PCTs.

The Home Pod follows the same principle; it can be used at home to monitor long-term conditions. For example, our systems going out in Scotland enable patients with COPD to carry out day-to-day tests at home. If the tests show the patient is getting worse or better, they are set to tell the doctor, nurse or carer to take action. This saves the patient having to go to the GP surgery or hospital to be monitored. The Home Pod is purchased by councils, GP surgeries, private healthcare providers and care homes.

What happens in your typical working day?

Each week is different. This week is office-based, following up demos, contracts and e-mails. Next week I have a lot of demos around the country. I demonstrate equipment to people, show them how to use it and how it can benefit them. Our product is not designed as an off-the-shelf item; you can change it to fit the problem. For example, where the Home Pod is used with COPD patients in Scotland, the product is adapted to fit that illness. Customers can actually see the benefits; rather than be told what they want, they can have what they want. Not many products out there offer that kind of flexibility.

We’re selling both a product and a service. There’s a service agreement, and customer support is ongoing. Using account managers, we install the product, show the staff how to use it, and follow up with a fortnightly call or e-mail to see how it’s going. After the system has been installed we can move it, change the configuration, set up a new language or questionnaire. All the way down the line, we can change the product to meet the customer’s requirements.

Following the installation, I speak to clinical staff and patient user groups about using the system. Patient user groups help us to improve the user interface of the system, and come back on details that we might overlook. They represent the people we’re trying to help.

About 70% of my working life is spent travelling, selling and dealing with customers. That’s the part I enjoy most, and the customers pick up on that. We work hard to develop customer relationships, rather than having a “What number are you?” kind of attitude. It’s quite labour-intensive, but you get much better results.

How do you see your market evolving in the future?

The benefit of our clients telling us what they want is that one client leads on to another. Our marketplace is getting much bigger. We’re looking to expand into the area of sports healthcare, helping people to stay healthy through exercise and weight control – a proactive healthcare strategy, rather than a reactive one.

 

 

Tags:

Medtech Features

A Day in the Life

by Admin 1. April 2008 14:06

   

 

 

 

In the seventh of our series on healthcare industry professionals, Duncan Mills, Sales Manager for Telehealth Solutions Ltd, talks to On Target about his working life.

What is the chief product line that you sell? Who are your customers?

We have two main products: the Surgery Pod and the Home Pod. The Surgery Pod goes into a GP surgery or other health area (such as a pharmacy). It enables patients to carry out basic health checks for themselves: blood pressure, weight, alcohol consumption, personal anxiety questionnaires – all the common questions that doctors and nurses usually have to go through when seeing a patient. It can be kept in a separate room or in the reception area. The Surgery Pod is purchased mostly by GP surgeries, although we’re also gaining increased traction with the PCTs.

The Home Pod follows the same principle; it can be used at home to monitor long-term conditions. For example, our systems going out in Scotland enable patients with COPD to carry out day-to-day tests at home. If the tests show the patient is getting worse or better, they are set to tell the doctor, nurse or carer to take action. This saves the patient having to go to the GP surgery or hospital to be monitored. The Home Pod is purchased by councils, GP surgeries, private healthcare providers and care homes.

What happens in your typical working day?

Each week is different. This week is office-based, following up demos, contracts and e-mails. Next week I have a lot of demos around the country. I demonstrate equipment to people, show them how to use it and how it can benefit them. Our product is not designed as an off-the-shelf item; you can change it to fit the problem. For example, where the Home Pod is used with COPD patients in Scotland, the product is adapted to fit that illness. Customers can actually see the benefits; rather than be told what they want, they can have what they want. Not many products out there offer that kind of flexibility.

We’re selling both a product and a service. There’s a service agreement, and customer support is ongoing. Using account managers, we install the product, show the staff how to use it, and follow up with a fortnightly call or e-mail to see how it’s going. After the system has been installed we can move it, change the configuration, set up a new language or questionnaire. All the way down the line, we can change the product to meet the customer’s requirements.

Following the installation, I speak to clinical staff and patient user groups about using the system. Patient user groups help us to improve the user interface of the system, and come back on details that we might overlook. They represent the people we’re trying to help.

About 70% of my working life is spent travelling, selling and dealing with customers. That’s the part I enjoy most, and the customers pick up on that. We work hard to develop customer relationships, rather than having a “What number are you?” kind of attitude. It’s quite labour-intensive, but you get much better results.

How do you see your market evolving in the future?

The benefit of our clients telling us what they want is that one client leads on to another. Our marketplace is getting much bigger. We’re looking to expand into the area of sports healthcare, helping people to stay healthy through exercise and weight control – a proactive healthcare strategy, rather than a reactive one.

 

 

Tags:

Medtech Features

Are we there yet?

by Admin 1. April 2008 14:04
 

 

Managing a medical technology sales account is no job for a passenger. Chris Cummins of OTD offers some critical signposts to help you get to success as an Account Manager – and enjoy the journey.

Last year, many companies in the medtech industry started to realise that if they don’t radically change their approach within the present environment, they face the prospect of ceasing to exist.

There’s no doubt that you will have seen, heard or had a gut feeling for this, and you may have resolved to do something about it. Whether your organisation is making things happen, watching others make things happen or wondering what on earth is happening, one thing most of the clients we’ve spoken to agree on is that the role of the Account Manager has never been more important.

Whether you are just about to embark on the journey of becoming an account manager or have been driving that vehicle for some time, here are some thoughts that could make a significant difference to your year.

What it takes

What skills and attributes do great account managers have? We posed this question to 120 account managers and their managers in the course of our work in 2007. Most of them agreed that great account managers display the following skills and attributes:

Key skills Attributes
Planning
Marketing
Relationship building
Problem solving
Negotiating
Opportunity creating
Organisation
Communicating
Presenting
Selling
Focused
Diplomatic
Tenacious
Flexible
Independent
Team player
Opportunity seeker

Imagine that these skills and attributes are your destination – which means a place where you are using these skills and attributes every day. Answer these questions:
• Is your destination in sight or over the horizon?
• What would be halfway between your goal and where you are now?
• What will you be doing differently when you get there?
• What milestones have you created to help you break up the journey?
• How motivated are you to reach the destination?

These are questions that great account managers keep asking themselves throughout the year. You might like to compare your answers with your manager’s perception of where you are.

Bad drivers

Although we’re not focusing on poor performers in this article (they tend not to read articles that could help them improve), here are seven deadly sins we’ve seen committed while on field visits over the years that we know you wouldn’t commit:
1. Poor objection handling
2. Insufficient listening
3. Failing to ask enough questions
4. Total lack of empathy
5. Failing to ask for the business
6. Failing to find out what customers truly want
7. Separating sales from service.

If you were driving a car without following signs or reacting to other drivers, what would be your chance of reaching the destination? None – yet why do so many account managers do some or all of these and still expect to improve their sales or market share? Insanity is doing the same thing over and over again and expecting different results.

Nothing on account

So what do great account managers do? In conversations with our clients last year, we identified five characteristics:
1. Great account managers have a clear picture of their desired outcome. They don’t wish things would happen, they make them happen. If an organisation has a poor relationship with the account manager’s company, they make sure that relationship changes for the better.
2. They take massive action towards achieving their desired outcome. They make sure most of their activities are related to that desired outcome, and question anything that doesn’t seem linked to the destination.
3. They notice what’s happening, and turn whatever is changing in their environment into an advantage to them and the company. 4. They are happy to change their approach if something doesn’t seem to be working, rather than waiting for their manager to ‘coach’ them or, even worse, expecting different results.
5. They don’t pay lip service to the term ‘sharing best practice’. They are obsessed with modelling excellence. They look for examples outside the industry if necessary.

If you do these things consistently, you will without doubt make a massive difference on territory.

The company perspective

Every company has its own expectations of account managers. Having discussed these with account managers and their managers within various client organisations, we can list some general expectations that your company will have of you:
• Understand all aspects of the account.
• Proactively develop more business with the customer.
• Establish strong relationships with the decision-makers in customer organisations.
• Build a wide awareness of your company’s capabilities within the account.
• Handle the account professionally on a day-to-day basis.
• Develop a true business partnership with the account.

The clearer you are about your company’s expectations, the better the chance you have of delivering.

Customer expectations

The more the account manager can stand in the customer’s shoes, the easier it is to build a real partnership. We’ve found that customers expect to see, hear and feel these qualities in an account manager:
• Be the main link into your company for all issues.
• Understand the customer’s business, market needs and working environment.
• Sell the customer products or services that help them achieve their objectives.
• Add value to the business relationship with your company.
• Capitalise on market opportunities and, when possible, identify new and exciting business challenges.
• Always act professionally and with integrity.

One medium-sized medical devices company that made the decision to adopt an account management approach at the beginning of 2006 discussed the impact of taking that approach on their 2007 results... They exceeded their sales target by 57%.

Getting into gear

At this stage, you have a clear picture of your account management destination and how to reach it, and you’ve had a chance to try on your customers’ shoes and gain insight into their expectations.

If you really want to make significant inroads for the rest of this year, here are three things you can do now that could mean the difference between you having a smooth ride to success or ending up on the hard shoulder:
1. Make a list of your accounts, prioritise them and decide why each one is important. Ask your colleagues in other departments in your company the same question. How does your list compare with theirs?
2. Ask your main contacts in your accounts what their expectations are of you as the account manager. If you don’t know them well enough to do this, you need to develop closer business relationships.
3. Ask your manager what his/her expectations are of you as an account manager.

If this is all new to you, there’s plenty to be getting on with to make this year the one when you really make that mark on your career you’ve always promised yourself.

Devices and solutions

Can account management work in the medical devices sector? Of course it can – if it follows the principles discussed here. As time goes on, we’ll see more and more organisations in this industry reaping the benefits in a way that the company described below has.

One medium-sized medical devices company that made the decision to adopt an account management approach at the beginning of 2006 discussed the impact of taking that approach on their 2007 results. Their customers are a mixture of GPs, community pharmacists and nursing homes. The sales management team took the decision to adopt all the steps discussed above. They exceeded their sales target by 57%.

When asked how surprised they were by these results, they said their new approach gave them the chance to refocus their business. The biggest challenge they faced was helping the whole organisation to change behaviour. Once they had the infrastructure to support their plans, the results were not a surprise.

OTDChris Cummins is a Director of the business consultancy OTD, which specialises in corporate coaching and account management. For more information, visit www.otd.uk.com or call 0845 224 1775.

 

Tags:

Medtech Features

Executive Careers

by Admin 1. April 2008 14:03
 

 

Sales Management Marketing Directorships

Planning for success – advice from Zenopa

The range of medical device suppliers to the multi billion pound NHS is highly fragmented, and comprises a few major companies, a myriad of medium companies, small companies and sole traders! The vast majority of these organisations do not have a training department and many do not have a dedicated Human Resources individual. From a company’s view point this hampers succession planning and from your point of view this stymies your personal development. Taking responsibility for your career is therefore a necessity for long term income security.

Consider the arithmetic of relevant job opportunities

Take time to consider the arithmetic of finding relevant job opportunities and the recruitment pathway. The management ratios of manager-to-managed lies between 1 to 6 and 1 to 8. Recruiting for a sales vacancy virtually always requires sourcing an external candidate as there is no internal feed structure, whereas for executive positions there is the sales team to call on and it is usually desirable to promote an individual from within. It is also true to say executives tend to stay in roles for longer than salespeople. All of the above factors contribute to executive vacancies representing c.15% of a company’s commercial vacancies, with sales vacancies making up the remaining c.85%. The opportunity to apply for the limited number of available executive vacancies is further compounded by most being appointed internally. When an executive vacancy becomes open to external candidates you need to review it.

The right place at the right time

Your first executive position is all too frequently a case of being in the right place at the right time. A classic example is when a sales manager has moved on and you are their most senior/successful direct report; perhaps you’ve expressed an interest in the job, or perhaps you moved into a product specialist role that became an office based product manager position, you’ve moved into marketing! These initial career breaks are where most individuals careers languish.

In their comfort zone

Often you find yourself in a comfort zone, not undertaking personal development with long term career growth and financial stability compromised. You must now move into a consolidated position to make a career breakthrough. Gain sponsorship for recognised external training from your employer, be this sales management or marketing. In either case you also need financial management, to implement this training in your job role and audit your own performance before and afterwards. Having done this you are in a good position to increment your salary internally. Perhaps, more importantly, you can communicate about your management or marketing role in a universal language and framework that other employers can recognise and value.

Increase your own personal market value

Identification and recognition of your executive skills also broadens your appeal beyond your current product niche, and enables you to broaden the number of employers that are interested in you. Frequently individuals are labelled with their niche product area. Niches are excellent whilst expanding as they disproportionately escalate your value, however niches also fall into decline and if you become unemployed can be a career closing trap.

Career closing traps

And when do those career closing traps occur? Usually when events out of your control occur – mergers, takeovers, liquidations, product sales/acquisition, changes of company strategy or changes of more senior executives. Plan to ensure that your career encompasses a diversity of product areas and formalised executive training and as such demonstrates transferable executive skills that enables more employers to consider you.

A plan for the scarcity of job transition opportunity

But also plan for the scarcity of job transition opportunity. That is you need to ensure you are informed. You have to take proactive steps, to ensure you are passively being kept in touch with market opportunities. We suggest that such a plan should, as a bare minimum, encompass the following criteria:
• ensure you are qualified
• evidence your success in the universal language of your discipline
• plan your next career move
• keep informed: sign-up to Zenopa executive updates.

Profile: Mark Denton

Mark DentonBefore commencing a medical recruitment career some 19 years ago, Mark enjoyed his time in medical sales with Becton Dickinson. In 1991Mark founded Zenopa (then branded as Zenith) and over the past 17 years this organisation has probably placed more people in Medical Devices than any other. Today Zenopa is a multi-million pound recruitment business with over 30 personnel and still enjoying strong growth. Over these 19 years Mark has seen first hand career successes and failures. This article makes you privy to some of that insight.

Jane Whiley

 

 

For the executive update service please contact our Executive Recruiter, Jane Whiley now in her fifth year with Zenopa 0844 980 9849 jane@zenopa.com

 

Tags:

Medtech Features

The burning question

by Admin 1. April 2008 14:01
 

 

What is NICE doing to support innovative health technologies?

Sir Michael Rawlins, Chairman of the National Institute of Health and Clinical Excellence (NICE), talks to On Target about the role of medtech in a changing NHS.

How will NICE support the emphasis on health innovation that Lord Darzi’s report calls for? In particular, how will it support the work of the new Health Innovation Council?

Quite clearly, we could do more in looking at the clinical and cost effectiveness of new, innovative approaches to healthcare. I’m a member of the HIC, so that’s a very direct way in which NICE is involved. It’s early days for the HIC: its precise agenda is still being determined by the department as well as by its members, but there are a number of ways in which NICE can be helpful.

But of course, one important thing is: what do we mean by innovation? We’re talking about two things: product innovation and process innovation. It’s not just about new technologies, but about new ways of doing things. Ways that are more efficient, more effective, provide patients with better care, and so forth. It’s a complicated issue, and we need to get to get an understanding of what in the health service constitutes innovation. Because something is new or works in a different way doesn’t mean it’s innovative. It also has to give value. That’s where some of the discussions lie.

A growing theme in the NHS is electronic healthcare – in particular, remote patient monitoring. How does NICE currently view the prospects for e-health? Can you give an example of an e-health initiative that strikes you as having particular promise?

Clearly, NICE is very interested in looking at and evaluating any technology that improves care, and the things you’re talking about have the potential to improve care and make care more effective, efficient and convenient. In theory, the electronic health record could be extraordinarily helpful to us by providing a means by which we and other people can monitor the performance of new products in real time. There are other sorts of remote technology that people are increasingly interested in using, and I’m sure many will find a place.

We look at new interventional procedures at NICE, their safety and efficacy. One of our great difficulties is that quite often something looks like a good idea, but we need further assessment of its effectiveness and safety. We don’t have the backing and support of a devices company, and at the present time we don’t have a mechanism by which we can monitor during routine care whether all these things are working out in practice. The electronic medical record can offer that as a very real potential. It has other advantages, such as finding people who might be appropriate for clinical trials.

How is NICE helping the NHS to shift its overall emphasis from acute care to preventative care and treatment in the community, thereby meeting the needs of an ageing population? How is it encouraging the medtech industry to develop new products and services that address these needs?

We have a very active and live programme of giving public health advice – not just to the Department of Health, but much more widely. For us, public health means the collective action of society to improve the health of the population as a whole. As Derek Wanless pointed out, unless we engage fully with public health, our healthcare system’s going to be broke by about 2020.

The major public health problems relate to alcohol, smoking, substance misuse, teenage sex and obesity. We have a very active public health agenda that’s producing all sorts of advice to the NHS and the wider public health community on measures to help those problems – such as stopping smoking in the workplace. This kind of activity, provided that our advice is implemented and extended, has great potential benefits for society. Not least because it offers the opportunity of giving bed room, so that with the ageing population and increasing demands for healthcare we can take advantage of medical advances for the future.

A closely related challenge for the NHS is the development of new models for helping people to maintain long-term conditions (LTC). How does NICE view that area of healthcare?

We’ve produced a fair number of guidelines on the maintenance of LTC (in fact, two-thirds of our guideline programme has been devoted to those areas), and that trend will continue. Most people with LTC don’t just have one, they have two, three or four, and handling combinations of LTC is something we’re not very knowledgeable about. Clinical studies usually look at a rather clean population, but actually when medical treatments are used in the real world they’re used in people with multiple diseases. How that works out, what steps you take, what the interactions are between the various forms of treatment – these are problems that every healthcare system has to deal with.

What should the main priorities be for the medtech sector?

Where people in the medtech business know the technical advantages of a treatment, they also have to remember that whatever is done happens in the context of a particular healthcare system. That can make it difficult for them, as they have to deal with all kinds of different healthcare systems across the world. Nevertheless, as far as Britain is concerned, we want new forms of medical technology that will improve the health of patients at a price that the NHS can afford. That’s quite tricky sometimes.

‘We want new forms of medical technology that will improve the health of patients at a price that the NHS can afford.’

 

Tags:

Medtech Features

News Company and Careers

by Admin 1. April 2008 14:00
 






Stryker and Medtronic among UK’s best employers

THE SUNDAY TIMES has named medical device companies Stryker and Medtronic in its list of the 100 ‘Best Companies To Work For’ in the UK.

Stryker UK was ranked as the 32nd best company to work for, moving up from 44th in 2007. Medtronic UK made its debut appearance in the list at 63rd place.

Stryker UKThe Sunday Times Best Company to Work For survey ranks companies on the basis of feedback from employees. Participating companies are evaluated on a wide range of criteria to determine overall employee satisfaction. The 2008 listing was based on over 180,000 entries from 868 companies.

STRYKER UK, a leading company in orthopaedics and wider health technology, saw its place in the listing move up 12 places to 32nd.

Louis Efron, Human Resources Director, told On Target: “Because healthcare is such a demanding and competitive industry, it is absolutely critical that we have the very best people working for us. We have consistently grown our operating income by 20% per annum for the past 28 years simply because we have great people making, marketing and selling great products.”

Mr Jonathan Eldridge, Consultant Orthopaedic Surgeon at the Avon Orthopaedic Centre in Bristol, commented: “It really doesn’t surprise me that Stryker have moved so impressively up the Top 100 league table! Every representative of Stryker’s I have ever met shines. They seem to have a genuine interest in what’s best for me, and more importantly my patients.”

Based in Newbury, Berkshire, Stryker UK markets, sells and distributes a broadbased range of products in orthopaedics and other medical specialties.

MEDTRONIC UK was ranked 63rd among the 100 best UK companies to work for in the Sunday Times survey, and also received a 2-star rating for being an outstanding organisation.

“We will use this success and the feedback we receive from the process to build on the work we have already started to make Medtronic an even better place for our employees to work,” said Geoff Morris, Medtronic’s Regional Vice President UK and Ireland.

Medtronic UK

Feedback from Medtronic staff indicated they feel they can make a difference to the firm (77%) and contribute to its success (81%), feel proud to be working there (85%) and find their jobs stimulating (78%). Medtronic gained the survey’s third highest score (84%) for making a positive difference to the world we live in.

Medtronic sells medical devices and services to help people with chronic diseases. The company’s UK subsidiary has been based in Watford since 1987.

Medtech SME sponsors global conference

UK MEDICAL DEVICE COMPANY Aircraft Medical sponsored the 14th World Congress of Anaesthesiologists (WCA) in Cape Town, South Africa last month, alongside Baxter and Draeger.

This sponsorship reflects Aircraft Medical’s growing importance in the field of airway management. Held every four years, the WCA is the foremost world conference for anaesthesia professionals.

Matt McGrathThe company’s McGrath® Series 5 Portable Video Laryngoscope was demonstrated by a panel of US and European experts at the congress.

Matt McGrath, Founder and CEO of Aircraft Medical, said: “We are aiming to position the McGrath as a globally recognised brand and to underline this, we are delighted to sponsor this market-leading conference.

“Our product has recently been put into use at the world’s largest hospital (the Chris Hani Baragwanath Hospital) and at the Groote Schuur Hospital, the home of the world’s first heart transplant, both of which are in South Africa.”

Matt McGrath was named ‘Young Scot of the Year’ for 2008 by the Institute of Contemporary Scotland, in recognition of achievements in creating new technology and advancing healthcare with Aircraft Medical.

Medipex wins Innovator Award

Medipex receives awardMedipex, the NHS Innovation Hub for Yorkshire and Humber, has won the region’s ‘Innovation Champion 08’ award.

The Innovator/08 Awards were presented by broadcaster Michael Portillo in a ceremony at Leeds Town Hall, hosted by regional development agency Yorkshire Forward to showcase the best of Yorkshire and Humber’s innovative companies.

Portillo noted Medipex’s achievement in identifying 600 ideas for healthcare-related innovations. Medipex has played a direct role in creating five new businesses and bringing 27 new products to the market.

Richard Clark, Chief Executive of Medipex, said: “This award recognises the hard work and efforts of all our staff, as well as that of NHS organisations from around the region. Winning a truly cross-sector award like this shows that the healthcare sector within Yorkshire and Humber is at the forefront of innovation and development.”

Medipex is one of a national network of NHS innovation hubs that manage and exploit intellectual property arising from within the NHS.

G2 appoints Northern Regional Manager

G2 Sales Recruitment has appointed Kirstine Morris as Regional Manager to head up its new Northern Office in Newcastle. The appointment strengthens the company’s permanent and contract resourcing solutions to the healthcare market.

“Kirstine brings G2 a wealth of healthcare experience as a nurse, sales person and more recently a National Sales Manager in the medical device sector. Her knowledge is a fantastic benefit to our clients and candidates, and by heading up our new Northern Office we can now offer a truly national coverage,” said Paul Budd, Manager at G2.

Kirstine Morris“Kirstine’s skills in recruiting healthcare sales professionals for her own team previously, and her high levels of understanding within the NHS and the private sector, mean she can bring an extra dimension to our team. We all look forward to her coming on board.”

HSP appoints new Web Manager

Jagdeep OubhieHEALTH SECTOR PUBLISHING has appointed Jagdeep Oubhie as Web Manager.

Jagdeep, who has worked at HSP for almost two years, will be responsible for managing the company’s online portfolio including www.healthcarejobs.co.uk and www.ontargetmag.com.

“I am thrilled to have been offered this important position and to take on a new challenge,” said Jagdeep. “Online strategies are now central to the growth of businesses across all sectors and publishing is no different. The opportunity here at HSP is very exciting. I have come on board with a fresh new outlook for our websites and have my own ideas of how we can further improve the sites for our growing user-base of clients and candidates.”

As Business Development Manager, Jagdeep helped to develop HSP’s service sector business and was responsible for introducing the company’s unique, targeted products to new markets.

For more information on HSP’s websites, contact Jagdeep on 0870 609 2834 or jagdeep.oubhie@healthpublishing.co.uk.

Advance Recruitment goes for Gold

Abbie KirkhamHEALTHCARE RECRUITMENT specialist Advance Recruitment Solutions has launched a ‘Gold’ graduate service.

Advance’s standard service offers a traditional contingency approach to recruitment, whereas its ‘Gold’ service offers candidates in the graduate market a special ‘Bestsellers’ programme of training and development while placing them in sales roles across the UK.

Abbie Kirkham, Sales and Marketing Director at Advance, has over six years’ experience of recruitment, covering both temporary and permanent sectors. She commented: “Graduate recruitment is so exciting! It’s so motivating to think we could be interviewing the next Managing Director or Sales Director of the future!”

However, Abbie noted, graduate recruitment is about interviewing thoroughly to ensure the best service possible. “We interview every candidate individually to ensure they are the right fit for a company. We take our time to get to know clients, and we extend the same service to our graduates.”

Tags:

Medtech Features

All together now

by Admin 1. April 2008 13:59
 

 

Tony Davis, CEO of Medilink West Midlands, looks at how the Government’s plans for ‘polyclinics’ will impact on patients and health provision, and what opportunities they will create for the medical technologies sector.

On Saturday 16 February, the BBC announced: “One-stop clinics ‘are the future’... Clinics manned by a single doctor should be replaced by one-stop health shops run by several GPs, Health Minister Lord Darzi has told the BBC. So-called ‘polyclinics’, which house GPs alongside medical services normally offered at hospitals, are better suited to patients’ needs, Lord Darzi said.”

The Government has said it expects 150 polyclinics to be built across England. This represents a significant change in the infrastructure of healthcare provision. But what are the implications for industry?

Don’t get acute

Lord Darzi’s recent announcement on polyclinics confirms the Government’s intention to devolve as many services as possible to the community, taking the pressure off (and reducing the costs of) acute hospital services. This is a trend that Medilink West Midlands has been tracking on behalf of industry for the last couple of years, and which has impacted on the remote diagnostics and imaging initiatives of our own i-Health project.

Over the last year, MedilinkWM has detected a definite policy push from the DH to devolve NHS services such as outpatients, imaging and minor operations to the domain of the GP surgery, along with a push to enable patients to monitor their own healthcare successfully. It’s a moot point whether this is being done on the basis of delivering a better quality of public healthcare or reducing the costly acute hospital budgets.

This shift has been highlighted in the West Midlands SHA’s document Investing for Health, which clearly indicates the need for community-based healthcare and treatment to be delivered at home, and puts emphasis on self-help and people taking action to ensure they remain healthy. This implies greater delivery of medical treatment and specialist clinics through local GP services or polyclinics.

Opportunities for industry

Polyclinics and other devolved services will only be effective if the hospital can unbundle its products and technologies and then manage the communication between patient, polyclinic and hospital. This is a considerable challenge for the NHS, as changes in service delivery of this magnitude are generally disruptive if not tightly managed.

Lord Darzi has stated clearly that polyclinics will depend on GPs working together to provide a critical mass of service that will be able to deliver a new kind of experience to patients. GPs will also have a responsibility to liaise and report back to the acute service.

The NHS has struggled in the past with handovers and communication between departments within hospitals. Creating a service offering in multiple settings can only be achieved if the NHS works with industry to provide healthcare technology solutions.

The challenges that polyclinics present can provide multiple opportunities for technological solutions from industry – primarily in the fields of diagnostics, scanning, data handling, data storage, digital communications, software and hardware. Many companies who have provided technology or services that facilitate change in other sectors of the economy could potentially translate their offerings into this market.

There will also be changes in the way equipment is procured that should be factored in by industry. NHS procurement is already complex, with multiple access points for companies trying to sell into it. Now many minor operations and diagnostic procedures will be carried out in a PCT setting for the first time, and will have to be commissioned in the community.

Polyclinics and other devolved services will only be effective if the hospital can unbundle its products and technologies and then manage the communication between patient, polyclinic and hospital. This is a considerable challenge for the NHS.

There are also indications that with changes to NHS procurement such as commissioning and contracting out, some of these services may be provided by commercial entities. There are signs that patients will need to contribute towards their own healthcare, and some areas are now giving patients vouchers towards the price of assistive technology equipment.

Who will manage this procurement? Who will companies target with their marketing and sales campaigns: GPs, hospital clinicians or even patients?

What is a polyclinic?

The polyclinics will be GP surgeries and other healthcare providers housed together in one building to provide a host of outpatient services. In other words, a one-stop shop for primary and community care, offering such services as:
• diabetes screening
• podiatry
• tissue viability
• leg ulcer clinics
• physiotherapy.

Polyclinics may also perform many day case surgeries that do not require an overnight stay, such as:
• contraceptive procedures
• minor hernia operations
• bunion operations
• varicose vein stripping
• orchidopexy
• laparoscopic procedures.

The DH’s Day Surgery: Operational Guide calls for “Assessment of the patient’s home circumstances, and for certain types of surgery, access to the patient’s home.” It also states: “Patients should be encouraged to arrange for a carer to stay with them, or for them to stay with a carer, until they are able to be self-caring. Lack of social backup should seldom be a reason to exclude a patient from day surgery.”

This indicates potential opportunities for new patient monitoring technologies to link back to the polyclinic in order to ensure the patient’s wellbeing following day case surgery.

Lord Darzi’s previous report highlighted the need for the NHS to work with industry and use new technology to provide innovative solutions as a way to address cost barriers and ensure that patients’ needs are met.

Lord Darzi stated: “Effectiveness is not just about making use of the very latest treatments and technologies. It is also about ensuring that patients receive well co-ordinated and integrated care.

“Nationally, I believe we should focus on facilitating innovation and on creating a clear quality framework for healthcare.”

Watch this cyberspace

Continuing from our i-Health project, over the next few years MedilinkWM will be trying to understand the way this new market opportunity is panning out – as well as pushing for answers on how equipment and services will be procured.

We envisage that there will be a growing provision of private services and products to monitor health and provide healthcare services. For example, Philips has recently dropped its consumer goods and will be concentrating on electronic healthcare, mainly for clinicians but also for the home market. We recently saw a set-top box it is developing for patients at home to access a variety of medical devices.

This is just the start. The polyclinics as they evolve will build their outreach and continuing care facilities through the use of electronic healthcare services, whether these are supplied by the NHS or social services or purchased directly by the patient. So look out for major telephone and Internet providers entering this market, and products appearing in your local superstores!

Tony Davis is CEO for Medilink West Midlands. For more information on MedilinkWM and the i-Health project, visit www.medilinkwm.co.uk. i-Health

 

Tags:

Medtech Features

News Products

by Admin 1. April 2008 13:57

 



An injection pen to remember

HumaPen MemoirTHE FIRST INSULIN PEN with a digital memory has been launched in the UK.

Lilly’s HumaPen® Memoir™, a reusable insulin pen for use with Lilly’s Humalog® and Humulin® insulin cartridges, enables patients to check the time, date and amount of the last 16 insulin doses taken.

Poor adherence to a dosing regimen, sometimes as a result of forgetting, is a common barrier to effective blood glucose control in insulin-dependent diabetics.

The HumaPen Memoir also has a ‘dialling’ system that enables users to set the dose by turning a knob. The correct dose appears in the display window. Any dosing error can be corrected without wasting insulin.

Sam Rosindale, a Diabetes Specialist Nurse at Torbay Hospital, said: “I often get phone calls from patients who can’t remember if they have had their insulin dose or not and asking what they should do in those circumstances. This device is not only helpful to patients but increases their confidence and provides reassurance.”

Simon O’ Neill, Director of Care, Information and Advocacy Services at Diabetes UK, commented: “For many people with diabetes, taking insulin is an essential element of their treatment. We welcome the development of any device which helps to make this part of their life easier to manage.”

For more details, visit www.lilly.co.uk.

Safety catheter wins design award

BD Venflon Pro            Safety IV            CatheterA SAFETY-ENGINEERED CATHETER designed to minimise infection risk to healthcare workers has won a prestigious ‘red dot’ design award.

The BD Venflon Pro Safety IV Catheter™ from BD Medical, available in the UK, has earned a ‘red dot: best of the best’ product design award in a competition that included more than 3,200 submissions from 51 countries.

The ‘red dot’ design awards, sponsored by the Design Zentrum Nordrhein Westfalen in Essen, Germany, recognise outstanding design quality and trendsetting in a variety of industries and product areas. An international jury selects the winners on criteria such as degree of innovation, functionality, ergonomics, longevity, ecological compatibility and clarity of function.

The BD Venflon Pro Safety IV Catheter is designed to help protect healthcare workers from exposure to bloodborne pathogens during the IV cannulation process. It combines features that help to prevent both needlestick injuries and blood splatters.

“This unique combination of features in the BD Venflon Pro Safety IV Catheter is an example of BD’s commitment to further improve healthcare worker safety through the development of innovative, safety-engineered devices,” said John Ledek, Vice President, BD Medical – Medical Surgical Systems.

For more details, visit www.bd.com.

Easier delivery for stent graft

MEDTRONIC INC has launched a new delivery system for its Talent™ Abdominal Stent Graft that enables it to slip through arteries with minimal friction.

The new delivery system improves the effectiveness of minimally invasive endovascular repair (EVAR) treatment for aortic aneurysms.

The Talent Abdominal Stent Graft uses the Xcelerant® Hydro Delivery System, which features a hydrophilic coating designed to aid navigation of the device through narrow and tortuous arteries by reducing friction with the artery wall.

“The Xcelerant Hydro Delivery System is a significant innovation that will make endovascular repair using the Talent Stent Graft a treatment option for more patients with abdominal aortic aneurysms,” said Dr. Dierk Scheinert, MD, PhD, of Park-Hospital and University of Leipzig – Heartcenter in Germany. “It will simplify the procedure for endovascular interventionalists in treating patients whose iliac arteries are difficult to navigate when they are small and tortuous.”

The Xcelerant Hydro Delivery System represents the seventh generation of innovation for the Talent Abdominal Stent Graft, which was introduced in Europe in April 1998. In bench testing, the Xcelerant Hydro Delivery System was shown to generate a 99% reduction in friction compared to the previous delivery system.

For more details, visit www.medtronic.com.

A premiere for Artiste™

Artiste SolutionThe Derby Hospitals NHS Foundation Trust has placed the first UK order for the Artiste™ Solution from Siemens for its new radiotherapy department.

The new system has been designed to image and treat a greater number of patients in a shorter timescale, and to provide a high standard of comfort to patients during treatment.

Artiste is an integrated and comprehensive imaging and treatment solution designed for Adaptive Radiation Therapy (ART). It delivers a high-precision dose directly to the tumour while sparing healthy tissue.

Artiste is also the world’s first integrated 3D MVision™ Megavoltage and 3D kVision™ Kilovoltage In-Line Image-Guided Radiation Therapy system. Its fast and powerful imaging allows tumour size and shape to be closely monitored, while its 160 MLC™ Multileaf Collimator optimises the radiation dose by aiming according to tumour shape rather than size.

Andy Jeffery, Radiotherapy Sales Manager at Siemens, said: “Offering multiple imaging modalities from Megavoltage to in-room CT gives clinicians the flexibility to tailor the most effective treatment approach for each patient. The adaptable nature of the Artiste also means that the department is fully prepared for future advances in treatment procedures, including dose-guided radiotherapy.”

For more details, visit www.medical.siemens.com.

First high-field MRI for NHS hospital

THE UK’S LARGEST SPECIALIST CARDIOTHORACIC hospital has installed specially-designed shields to protect its staff from exposure to X-rays.

Cardiac catheter laboratories at Papworth Hospital in Cambridgeshire have installed Radpad shields from APC Cardiovascular. Independent studies have shown these to be the most effective means available to reduce scatter radiation from X-ray equipment.

The Radpad shields, which are sterile and lead-free, are placed directly onto the patient, providing the healthcare professional with a movable guard to protect against radiation while conducting a medical procedure.

Already used in a number of UK interventional centres, the Radpad shields are available in a variety of shapes and sizes: from general purpose shields to highly specialised versions for specific procedures such as biopsy and dialysis de-clotting.

Radpad shieldDr Munmohan Virdee, Consultant Cardiologist at Papworth Hospital, said: “Using the Radpad shields means our staff are much better protected against harmful radiation. It is lightweight and easy to use.”

Derrick Ebden, Managing Director of APC Cardiovascular, said: “Protecting staff against radiation exposure is vital. The Radpad shields dramatically reduce scatter produced from working with X-ray equipment, and this can protect the healthcare professional from the long-term effects of radiation exposure.”

For more details, visit www.apc-cardiovascular.co.uk.

New system allows tailored hip replacements

SMITH & NEPHEW ORTHOPAEDIC Reconstruction has launched a new hip replacement system in the UK and worldwide.

The new R3™ Acetabular System is a multibearing cup system used for total hip replacement.

By using a single set of instruments for all bearings, the R3 system gives surgeons a more flexible solution. The cup is also designed to reduce wear and subsequent need for revision surgery.

The Stiktite™ porous coating of the R3 enhances fixation and bony in-growth. The system combines BHR Metal on Metal technology (which has a 10-year benign clinical history), cross-linked polyethylene and Delta ceramics, giving a very low wear rate.

“A surgeon now has more options to treat the patient, and when combined with our excellent hip stems the R3 system presents a high-performance option that fits nicely into our growing portfolio of products for active patients,” said Joseph DeVivo, President of Smith & Nephew Orthopaedic Reconstruction.

“The R3 Acetabular system will now give me the flexibility to tailor the implant to each of my patients,” said surgeon Stephen McMahon of the Malabar Orthopaedic Clinic in Windsor, Australia. “This range of options allows me to provide the most suitable surgical solution for each individual, enabling patients to realise their best possible outcome.”

For more details, visit www.smith-nephew.com.

Tags:

Medtech Features

On Target Events

by Admin 1. April 2008 13:56

 

 

Convergent Technology

‘Conquering Clinical Challenges Together’, the third in a series of Convergent Technology events, was held at the Beardmore Hotel and Golden Jubilee National Hospital, Clydebank on 12 March 2008. It featured presentations from respected clinicians, supported by 23 companies showcasing technologies with the potential to meet future healthcare needs.

Attracting over 100 delegates, the event was aimed at professionals from a range of technology backgrounds: doctors, nurses, physiotherapists and other healthcare professionals; medical device industry professionals; academics and researchers; and organisations and companies providing support services to the medical device industry.

Technologies on display from 23 showcase companies included:
• Blaze Venture Technologies’ proprietary products for rapid MRSA screening and surface decontamination
• Lab901’s microbiological diagnostics for bacterial, viral and fungal targets in the hospital and health protection sectors
• PAL Technologies’ miniature acceleration sensing solutions for healthcare applications
• PWB Health’s hand-held BreastLight device, which adds the dimension of internal sight to a woman’s breastchecking routine.

Bringing talents together

Keynote Speaker Dr Aileen Keel, Deputy Chief Medical Officer for Scotland, said: “Scotland has particular healthcare needs and these clinical needs, together with the remote nature of many parts of our landscape, present us with a unique set of challenges.” The way forward for medical innovation, she argued, was collaboration across multiple disciplines and industry sectors.

A presentation on Assistive Technologies/Remote Monitoring was given by Professor David Godden, Director of the Centre for Rural Health at the University of Aberdeen, who talked about the public enthusiasm for e-health and the role of telemedicine in the changing primary care service configuration of remote and rural Scotland. He also touched on the integration of mobile phones with physiological measurement, and the advent of facilities such as Cisco Systems’ HealthPresence Pod – a self-service healthcare stand concept that contains a range of medical devices (including blood pressure cuffs, glucose monitors, audioscopes and stethoscopes) which upload data into an electronic medical record.

In another presentation, Professor Hing Leung (Professor of Urology/ Surgical Oncology and Honorary Consultant Urological Surgeon, University of Glasgow/Beatson Institute for Cancer Research) outlined the opportunities that existing technologies such as robot-assisted surgery offer in the diagnosis and treatment of prostate cancer. He also discussed the potential benefits of evolving therapies and technologies in the treatment of prostate cancer, including new imaging devices.

Jim Shepherd, Professor of Vascular Biochemistry, University of Glasgow and Honorary Consultant, Glasgow Royal Infirmary, discussed the methods used to identify those at risk of a coronary event. In considering unmet need in the assessment of cardiovascular risk, he looked at a number of potentially novel techniques: electrocardiography, carotid intima-media thickness and coronary artery Ca2+ scoring, endothelial dysfunction and c-reactive protein. His conclusion was that coronary risk assessment remains an imprecise art, with scope for new technologies.

Making connections

The Convergent Technology event was not only a valuable networking opportunity, but was also highly informative about areas of clinical need that invite technological solutions. One exhibitor is already working on two opportunities as a direct result of the event.

The event was jointly organised by Stirling University Innovation Park (SUIP Ltd), Medical Devices in Scotland (MDIS), Scottish Health Innovations Limited (SHIL), the ED Technology Support Centre for Scotland (EDTC) and Nexxus, the West of Scotland BioScience Network.

Report by Nexxus, the West of Scotland Bioscience Network.
For more information, visit www.nexxusscotland.com.
For more information about PWB Health, visit www.breastlight.co.uk.


 

Tags:

Medtech Features

News General

by Admin 1. April 2008 13:53
 







New UK centre for robotic surgery

Professor Lord Ara Darzi, Lady Helen Hamlyn,            Sir Richard Sykes and Professor Guang-Zhong YangA NEW LONDON-BASED CENTRE FOR ROBOTIC SURGERY will push forward the integration of robotics into healthcare.

The Hamlyn Centre for Robotic Surgery at Imperial College London will draw together world-leading experts to create an international centre of excellence for medical robotics in the UK.

The campaign to establish the new centre was initiated by £10m of philanthropic funding from the Helen Hamlyn Trust and from Lady Hamlyn.

The Centre will be co-directed by two UK pioneers in medical robotics: Professor Lord Ara Darzi, who holds the Paul Hamlyn Chair of Surgery at Imperial College London, and Professor Guang- Zhong Yang, Director of Medical Imaging at Imperial.

The Centre aims to develop advanced robotic technologies that will transform keyhole surgery and create miniature ‘microbots’ with integrated sensing and imaging facilities for cancer surgery and treatment.

Lord Darzi said: “This funding will allow the team to leverage our existing research programmes in pursuing adventurous, fundamentally new technologies that will allow more widespread use of robotics in medicine and patient care.”

Sir Richard Sykes, Rector of Imperial College London, commented: “This will allow us to attract international talents and develop UK technologies that will transform the future development of medical devices.”

Scotland gains extra £8m for telecare

THE SCOTTISH GOVERNMENT has committed an additional £8 million to develop interactive home-based telecare services.

Over the next two years, local health, housing and social care partnerships will benefit from extra funding to expand telecare programmes that allow vulnerable people to live with greater independence and safety at home.

Partnerships in Highland, Inverclyde and West Lothian have received £150,000 extra funding for their Housing Demonstrator schemes, which provide a range of housing solutions for care at home.

The National Telecare Programme will receive an additional £4 million from the Scottish Government in 2008–9 and a further £4 million in 2009–10. The programme has already saved 1,800 hospital bed days and 6,900 care home bed days for NHS Scotland, leading to savings of approximately £2.9 million.

Minister for Public Health Shona Robison said: “I am delighted to announce an additional £8 million for the development of telecare services across Scotland over the next two years. These services will help support people to live independently, while providing peace of mind that help is at hand.

Shona Robison “I am looking forward to seeing the results of faster innovation and a new generation of interactive care services which promise far-reaching improvements to the quality of people’s lives.”

Suppliers on demand

A WEB-BASED LISTING of medical technology small and medium-sized companies (SMEs) for NHS Trust purchasers is due to go live this month.

The Suppliers Registration System is a searchable tool to help NHS Trusts develop and sustain commercial relationships with medtech SMEs in their region.

The system will enable Trusts to search for registered SMEs and forward details of purchasing requirements to them. SMEs will, in turn, be able to respond to purchasing requests directly from Trusts.

This will make it easier for smaller businesses to compete with more established major suppliers, and to build ongoing commercial relationships with Trust procurement departments. It will also allow purchasers within Trusts to ensure that they are sourcing the best deals for the region.

Richard Stone, Public Sector Contracts Manager at Medilink West Midlands, said: “In an environment where the public and businesses are becoming increasingly conscious of their carbon footprints and green credentials, the ability for NHS Trusts to be able to compare and contrast the products and services of locally-based SME suppliers is of significant importance. From an SME point of view, any opportunity to be able to gain a competitive advantage over more powerful, globally-based rivals will surely be welcomed with open arms.”

Charterhouse acquires Tunstall Group

James BuckleyCHARTERHOUSE CAPITAL PARTNERS, a private equity firm, has acquired a controlling interest in the Tunstall Group in a transaction worth £514m.

This valuation reflects the success of Tunstall’s e-health services over the last few years, and the anticipated growth in market adoption.

Tunstall now holds a market-leading position in 30 countries, having shifted its business focus from reactive social alarms to proactive and preventative telecare and telehealth solutions.

James Buckley, Chief Executive, Tunstall Group, said: “I am delighted to be working with Charterhouse. Our aim is to offer even more enhanced levels of support, drive forward our technology plans and work with our customers to provide effective solutions for a diverse range of people across the globe, and I believe we have found the right team to help us achieve our ambitions.”

Jeremy Greenhalgh, Partner, Charterhouse, commented: “It is clear that Tunstall is a very successful business with attractive solutions in a market that is experiencing ageing demographics and the emergence of lifestyle epidemics such as obesity and chronic disease. Governments around the world are recognising the compelling economics of telecare and telehealth, and I am looking forward to working with the Tunstall team to deliver its plans for the future.”

Budget supports innovative SMEs

MOVES TO MAKE THE PUBLIC SECTOR, including the NHS, more accessible to innovative small and medium-sized companies (SMEs) have been announced in the Chancellor’s 2008 Budget.

In his Budget statement, Alistair Darling announced that a review would be undertaken by Anne Glover of Amadeus to look at the barriers to SMEs winning government contracts and to consider a possible 30% target.

The Association of British Healthcare Industries (ABHI) welcomed these moves. Director General John Wilkinson said: “The challenge to achieving broader SME involvement in health is very substantial, following successive moves to centralise and consolidate NHS procurement on the basis that ‘buying big equals buying cheap’.

“A fundamental revision of policy is needed if the NHS and, more importantly, patients are not to be deprived of the enormous innovative potential of small British companies, which will in turn richly reward the Chancellor by delivering high value-added jobs for the economy.”

John WilkinsonThe Chancellor also announced a simplification of the tax system for small businesses and a reduction in corporation tax from 30% to 28%. As was announced in the 2007 Comprehensive Spending Review, the NHS will receive an average increase in resources of 4% per year.

Covidien to purchase Tissue Science Laboratories

GLOBAL HEALTHCARE PRODUCTS COMPANY COVIDIEN Ltd has launched a public tender offer for all outstanding shares in UK surgical implants company Tissue Science Laboratories held by UK residents.

Covidien will pay a total of approximately $80m. The Boards of Directors of both companies have approved the transaction, which is expected to be completed in the second calendar quarter of 2008.

Aldershot-based Tissue Science Laboratories is a specialist supplier of tissue implant products for surgical and wound care therapies. The company’s core technology is Permacol®, a collagen-based surgical implant used for complex and recurrent hernia repair.

“The acquisition of Tissue Science Laboratories will provide Covidien with a leading tissue repair technology and accelerate our entry into the rapidly growing biologic hernia repair market,” said Scott Flora, President, Surgical Devices, Covidien. “The Permacol product will complement our current soft tissue product offerings and will allow us to offer a full line of differentiated hernia repair products.”

Patrick Paul, Chairman, Tissue Science Laboratories, said: “Having successfully established Permacol as a class leading material in the rapidly developing biologic implant market, we are delighted to have now found a company in Covidien which shares our vision for the future potential of our technology platform.”

Tags:

Medtech Features

TextBox

Tag cloud

Calendar

<<  May 2013  >>
MoTuWeThFrSaSu
293012345
6789101112
13141516171819
20212223242526
272829303112
3456789

View posts in large calendar